Differential Expression Profile of miR-27b, miR-29a, and miR-155 in Chronic Lymphocytic Leukemia and Breast Cancer Patients

Filip, 2017, Expression of circulating miRNAs associated with lymphocyte differentiation and activation in CLL-another piece in the puzzle, Ann. Hematol., 96, 33, 10.1007/s00277-016-2840-6 Munker, 2011, MicroRNA profiling in cancer, Clin. Sci. (Lond.), 121, 141, 10.1042/CS20110005 Torre, 2015, Global cancer statistics, 2012, CA Cancer J. Clin., 65, 87, 10.3322/caac.21262 Yauk, 2010, Cross-platform analysis of global microRNA expression technologies, BMC Genomics, 11, 330, 10.1186/1471-2164-11-330 Krol, 2010, The widespread regulation of microRNA biogenesis, function and decay, Nat. Rev. Genet., 11, 597, 10.1038/nrg2843 Emery, 2015, Transcriptional and Epigenetic Regulation of Oligodendrocyte Development and Myelination in the Central Nervous System, Cold Spring Harb. Perspect. Biol., 7, a020461, 10.1101/cshperspect.a020461 Fan, 2010, DNA microarrays are predictive of cancer prognosis: a re-evaluation, Clin. Cancer Res., 16, 629, 10.1158/1078-0432.CCR-09-1815 Liu, 2008, Expression profiling of microRNA using oligo DNA arrays, Methods, 44, 22, 10.1016/j.ymeth.2007.10.010 Sato, 2009, Intra-platform repeatability and inter-platform comparability of microRNA microarray technology, PLoS ONE, 4, e5540, 10.1371/journal.pone.0005540 Bartel, 2009, MicroRNAs: target recognition and regulatory functions, Cell, 136, 215, 10.1016/j.cell.2009.01.002 de Planell-Saguer, 2013, Detection methods for microRNAs in clinic practice, Clin. Biochem., 46, 869, 10.1016/j.clinbiochem.2013.02.017 Schmittgen, 2008, Real-time PCR quantification of precursor and mature microRNA, Methods, 44, 31, 10.1016/j.ymeth.2007.09.006 Bottoni, 2014, MicroRNAs as main players in the pathogenesis of chronic lymphocytic leukemia, MicroRNA, 2, 158, 10.2174/2211536602666131126002337 Moussay, 2011, MicroRNA as biomarkers and regulators in B-cell chronic lymphocytic leukemia, Proc. Natl. Acad. Sci. USA, 108, 6573, 10.1073/pnas.1019557108 Iorio, 2005, MicroRNA gene expression deregulation in human breast cancer, Cancer Res., 65, 7065, 10.1158/0008-5472.CAN-05-1783 Schweiger, 2011, The power of NGS technologies to delineate the genome organization in cancer: from mutations to structural variations and epigenetic alterations, Cancer Metastasis Rev., 30, 199, 10.1007/s10555-011-9278-z Kim, 2018, MicroRNAs and metastasis: small RNAs play big roles, Cancer Metastasis Rev., 37, 5, 10.1007/s10555-017-9712-y Ouillette, 2011, The prognostic significance of various 13q14 deletions in chronic lymphocytic leukemia, Clin. Cancer Res., 17, 6778, 10.1158/1078-0432.CCR-11-0785 Danger, 2014, MicroRNAs, Major Players in B Cells Homeostasis and Function, Front. Immunol., 5, 98, 10.3389/fimmu.2014.00098 Lawrie, 2013, MicroRNAs and lymphomagenesis: a functional review, Br. J. Haematol., 160, 571, 10.1111/bjh.12157 de Yébenes, 2013, Regulation of B-cell development and function by microRNAs, Immunol. Rev., 253, 25, 10.1111/imr.12046 Mraz, 2013, MicroRNAs and B cell receptor signaling in chronic lymphocytic leukemia, Leuk. Lymphoma, 54, 1836, 10.3109/10428194.2013.796055 Li, 2011, MicroRNA expression profiling identifies activated B cell status in chronic lymphocytic leukemia cells, PLoS ONE, 6, e16956, 10.1371/journal.pone.0016956 Cui, 2014, MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia, Blood, 124, 546, 10.1182/blood-2014-03-559690 Ferrajoli, 2013, Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia, Blood, 122, 1891, 10.1182/blood-2013-01-478222 Liu, 2012, MicroRNA-21 targets the vitamin D-dependent antimicrobial pathway in leprosy, Nat. Med., 18, 267, 10.1038/nm.2584 Jorge, 2017, Characterization of MicroRNA Expression Profiles and Identification of Potential Biomarkers in Leprosy, J. Clin. Microbiol., 55, 1516, 10.1128/JCM.02408-16 Ajit, 2012, Circulating microRNAs as biomarkers, therapeutic targets, and signaling molecules, Sensors (Basel), 12, 3359, 10.3390/s120303359 Cambau, 2002, Molecular detection of rifampin and ofloxacin resistance for patients who experience relapse of multibacillary leprosy, Clin. Infect. Dis., 34, 39, 10.1086/324623 Faruq, 2015, microRNA: Diagnostic Perspective, Front. Med. (Lausanne), 2, 51 Tang, 2012, MiR-27 as a prognostic marker for breast cancer progression and patient survival, PLoS One, 7, 10.1371/journal.pone.0051702 Choghaei, 2016, Knockdown of microRNA-29a Changes the Expression of Heat Shock Proteins in Breast Carcinoma MCF-7 Cells. Oncol. Res. Featur. Preclin. Clin, Cancer Ther., 23, 69 Pei, 2016, MiR-29a promotes cell proliferation and EMT in breast cancer by targeting ten eleven translocation 1, Biochim. Biophys. Acta, 1862, 2177, 10.1016/j.bbadis.2016.08.014 Clurman, 1989, Multiple proto-oncogene activations in avian leukosis virus-induced lymphomas: evidence for stage-specific events, Mol. Cell. Biol., 9, 2657, 10.1128/MCB.9.6.2657 Lewis, 2005, Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets, Cell, 120, 15, 10.1016/j.cell.2004.12.035 Mattiske, 2012, The oncogenic role of miR-155 in breast cancer, Cancer Epidemiol. Biomarkers Prev., 21, 1236, 10.1158/1055-9965.EPI-12-0173 Sun, 2012, Serum microRNA-155 as a potential biomarker to track disease in breast cancer, PLoS ONE, 7, e47003, 10.1371/journal.pone.0047003 Cortez, 2012, Circulating MicroRNAs as Noninvasive Biomarkers in Breast Cancer, Recent Results Cancer Res, 195, 151, 10.1007/978-3-642-28160-0_13 Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Δ Δ C(T)) Method, Methods, 25, 402, 10.1006/meth.2001.1262